2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes
The 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies.
Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2022 ASCO Annual Meeting in June 2022.
This conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:
- Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options.
- Current and evolving paradigms in precision oncology approach for management of common malignancies.
- Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.
Call For abstract
Abstract submission deadline: July 31, 2022
Submit to one of the following categories:
- Basic science research
- Clinical research
- Quality-of-care research
- Outcomes research
- Case reports and case-series
Abstract decisions will be emailed to the first author by August 15, 2022
Click here to submit abstracts
Target Audience
- Hematologists/Oncologists
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
Learning Objectives
Upon successful completion of this educational activity on precision oncology, participants will be able to:
- Identify frequent molecular abnormalities across several common malignancies and understand appropriate timing of testing to detect these abnormalities.
- Interpret results of next generation sequencing and other biomarkers predictive of response to targeted therapies and recognize the challenges involved.
- Explain the role, including advantages and disadvantages, of different testing methodologies available for selection of targeted therapies.
- Plan optimal molecular-targeted treatment strategies for treatment of cancer.
- Outline emerging research, the mechanism of action, and the role of novel molecular-targeted therapies in clinical investigation for cancer patients.
All times below are listed in Mountain Standard Time.
Friday, October 7th, 2022
3:00 PM to 3:45 PM Registration
3:45 PM to 4:00 PM Welcome note from the conference chair - Neeraj Agarwal, MD
4:00 PM to 6:00 PM Session 1: Methods in Precision Oncology
Moderator: Christos Vaklavas, MD
4:00 PM to 4:20 PM Next generation sequencing for identification of molecular targets - James Ford, MD
4:25 PM to 4:45 PM Beyond sequencing – methods in identifying tumor biomarkers for targeted therapies - Vivek Subbiah, MD
4:50 PM to 5:10 PM Germline genetic testing for cancer prevention and treatment - Siddhartha Yadav, MD
5:15 PM to 5:35 PM Clinical utility of circulating tumor DNA in cancer treatment - Manish Kohli, MD
5:35 PM to 6:00 PM Q and A/Panel discussion
6:00 PM to 8:00 PM Dinner & Abstract Session
Saturday, October 8th, 2022
7:00 AM to 7:30 AM Breakfast and registration
7:30 AM to 8:45 AM Session 2: Precision oncology in breast cancer
Moderator: Paolo Tarantino, MD
7:30 AM to 7:45 AM Precision oncology in metastatic breast cancer - Mark Pegram, MD
7:45 AM to 8:00 AM Non-metastatic breast cancer - Christos Vaklavas, MD
8:00 AM to 8:45 AM Panel discussion
8:45 AM to 10:00 AM Session 3: Precision Oncology in Lung Cancer
Moderator :
8:45 AM to 9:00 AM Metastatic lung cancer - Katie Kerrigan, MO
9:00 AM to 9:15 AM Adjuvant treatment of lung cancer - Aaron Mansfield, MD
9:15 AM to 10:00 AM Panel discussion
10:00 AM – 10:30 AM Break
10:30 AM to 11:15 AM Session 4: Precision Oncology in GI Malignancies
Moderator: Chandrikha Chandrasekhara, MBBS
10:30 AM to 10:45 AM Precision Oncology in Colon cancer - Stacey Cohen, MD
10:45 AM to 11:00 AM Hepatobiliary and pancreatic malignancies - Chris Nevala-Plagemann, MD
11:00 AM to 11:15 AM Panel based discussion
11:15 AM – 12:00 PM Session 5: Precision oncology in gynecologic malignancies
11:20 - 11: 35 Key concepts on precision in gynecological malignancies - Theresa Werner, MD
11:35 - 12:00: Case discussion
12:00 PM to 1:00 PM Lunch
1:00 PM to 2:15 PM Session 5: Precision oncology in GU malignancies
Moderator: Benjamin Maughan, MD
1:00 PM to 1:15 PM Metastatic prostate cancer - Neeraj Agarwal, MD
1:15 PM to 1:30 PM Non-metastatic prostate cancer - Benjamin Maughan, MD
1:30 PM to 2:15 PM Q & A
2:15 PM – 2:30 PM Break
2:30 PM to 3:30 PM Session 6: Precision oncology in hematological malignancies
Moderator:
2:30 PM to 2:45 PM Precision oncology in acute leukemias - Tibor Kovacsovics, MD
2:45 PM to 3:00 PM Precision oncology in myeloma and lymphomas
3:00 PM to 3:30 PM Panel discussion
3:30 PM to 4:45 PM Session 7: Implementation science in precision oncology
Moderator:
3:30 PM to 3:45 PM Disparities in precision oncology and improving access to evidence-based testing for targeted therapies - Jack West, MD
3:45 PM to 4:00 PM Implementing precision genomics in busy clinical practice – how to?
4:00 PM to 4:15 PM Patient perspective in precision oncology
4:15 PM to 4:45 PM Panel discussion
4:45 PM to 5:00 PM Concluding remarks - Neeraj Agarwal, MD
Chandrikha Chandrasekharan, MBBS
Paolo Tarantino, MD
James Ford, MD, FASCO
Manish Kohli
Benjamin Maughan, M.D., PharmD
Christopher Nevala-Plagemann, MD, MSCI
Mark Pegram, MD
Vivek Subbiah, MD
Christos Vaklavas, M.D., Associate Professor
Howard (Jack) West, MD, Associate Professor, City of Hope Cancer Center, Los Angeles, CA
Siddhartha Yadav, Siddhartha Yadav, MD, FACP
Available Credit
- 9.50 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 9.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 9.50 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 9.50 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
REGISTRATION FEES
Physicians (non-industry) - $350
Non-physician HCP (non-industry) - $250
Industry representatives - $850
Fellow or resident - $150
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
Cancellation Policy
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
- No refunds will be issued if registration is cancelled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.